- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The evolution of preclinical models for myelodysplastic neoplasms ; volume:38 ; number:4 ; day:23 ; month:2 ; year:2024 ; pages:683-691 ; date:4.2024
Leukemia ; 38, Heft 4 (23.2.2024), 683-691, 4.2024
- Creator
-
Mina, Alain
Pavletic, Steven
Aplan, Peter D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02181-2
- URN
-
urn:nbn:de:101:1-2406211210132.273056369928
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mina, Alain
- Pavletic, Steven
- Aplan, Peter D.
- SpringerLink (Online service)
Other Objects (12)
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Functional characterisation of the mesenchymal cell-derived extracellular matrix in myelodysplastic neoplasms
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Functional characterisation of the mesenchymal cell-derived extracellular matrix in myelodysplastic neoplasms
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Functional characterisation of the mesenchymal cell-derived extracellular matrix in myelodysplastic neoplasms
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice